Ignite Creation Date:
2024-05-06 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03662126
Status:
RECRUITING
Last Update Posted:
2023-04-28
First Post:
2018-09-05
Brief Title:
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
Sponsor:
Kartos Therapeutics Inc
Organization:
Kartos Therapeutics Inc
Organization Data
Organization:
Kartos Therapeutics Inc
Class:
INDUSTRY
Study ID:
KRT-232-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kartos Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None